Article originally published in CRST.
Highlighting advantages such as increased patient comfort, a relaxed atmosphere, and greater surgical efficiency can significantly grow your ICL volume.
The World College of Refractive Surgery recognizes eight types of refractive procedures: LASIK, PRK, laser-assisted lenticule extraction, phakic IOLs, lens replacement, refractive cataract surgery, allogenic corneal inlays, and CXL. Lens-based refractive correction in particular is becoming a significant driver of market growth. Last year, Market Scope projected modest growth in refractive surgery overall but more aggressive growth in lens-based procedures, including phakic IOLs.1 Future Market Insights, moreover, has reported that the phakic IOL market is expected to grow at a compound annual rate of 8.1%, reaching $897.4 million by the year 2033 (Table).2
I have long supported lens-based refractive procedures and was an early adopter of Implantable Collamer Lens (ICL; STAAR Surgical) technology. The implantation of earlier ICL models was a two-step process, including a preoperative laser peripheral iridotomy. The introduction of the EVO ICL (STAAR Surgical) has streamlined the procedure by eliminating the need for an iridotomy and reducing the incidence of pupillary block and anterior subcapsular cataract formation, among other risks.3-5 The EVO has expanded patient eligibility and increased my confidence in offering the procedure to individuals with -3.00 to -6.00 D of myopia.
Click below to continue reading:
